Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Monteleone

Showing results (31-40 of 384) with videos related to

Pageof 39
Sort By:
Journal of Biomedicine & Biotechnology|June 16, 2012
Colorectal cancer chemoprevention by mesalazine and its derivativesCarmine Stolfi, Francesco Pallone, Giovanni Monteleone
Cancers|December 17, 2024
Hepcidin Is a Valuable Therapeutic Target for Colorectal CancerRachele Frascatani, Marco Colella, Giovanni Monteleone
Autoimmunity Reviews|June 19, 2013
Targets for new immunomodulation strategies in inflammatory bowel diseaseGiovanni Monteleone, Roberta Caruso, Francesco Pallone
Clinical Science (London, England : 1979)|October 24, 2015
Pathogenic aspects and therapeutic avenues of intestinal fibrosis in Crohn's diseaseFrancesca Zorzi, Emma Calabrese, Giovanni Monteleone
Expert Opinion on Investigational Drugs|May 14, 2016
Tofacitinib for the treatment of ulcerative colitisRoberta Izzo, Gerolamo Bevivino, Giovanni Monteleone
Discovery Medicine|October 17, 2009
Interleukin-21 in T cell-mediated diseasesGiovanni Monteleone, Massimiliano Sarra, Francesco Pallone
Journal of Clinical Medicine|February 27, 2026
Understanding Frailty in IBD: Implications for Clinical Outcomes and Multidisciplinary CareSilvia Salvatori, Irene Marafini, Giovanni Monteleone
Journal of Ultrasound|April 6, 2024
Clinical and ultrasonographic evaluation of uninjured dominant shoulder in amateur rugby players vs a control group: a pilot studyGiovanni Monteleone, Alfonso Tramontana, Roberto Sorge
Nutrients|October 5, 2019
Impact of Food Additives on Gut HomeostasisFederica Laudisi, Carmine Stolfi, Giovanni Monteleone
Journal of Crohn'S & Colitis|December 22, 2010
Th17 immune response in IBD: A new pathogenic mechanismFlavio Caprioli, Francesco Pallone, Giovanni Monteleone
Pageof 39

Showing results (31-40 of 384) with videos related to

Sort By:
Pageof 39
Journal of Biomedicine & Biotechnology|June 16, 2012
Colorectal cancer chemoprevention by mesalazine and its derivativesCarmine Stolfi, Francesco Pallone, Giovanni Monteleone
Cancers|December 17, 2024
Hepcidin Is a Valuable Therapeutic Target for Colorectal CancerRachele Frascatani, Marco Colella, Giovanni Monteleone
Autoimmunity Reviews|June 19, 2013
Targets for new immunomodulation strategies in inflammatory bowel diseaseGiovanni Monteleone, Roberta Caruso, Francesco Pallone
Clinical Science (London, England : 1979)|October 24, 2015
Pathogenic aspects and therapeutic avenues of intestinal fibrosis in Crohn's diseaseFrancesca Zorzi, Emma Calabrese, Giovanni Monteleone
Expert Opinion on Investigational Drugs|May 14, 2016
Tofacitinib for the treatment of ulcerative colitisRoberta Izzo, Gerolamo Bevivino, Giovanni Monteleone
Discovery Medicine|October 17, 2009
Interleukin-21 in T cell-mediated diseasesGiovanni Monteleone, Massimiliano Sarra, Francesco Pallone
Journal of Clinical Medicine|February 27, 2026
Understanding Frailty in IBD: Implications for Clinical Outcomes and Multidisciplinary CareSilvia Salvatori, Irene Marafini, Giovanni Monteleone
Journal of Ultrasound|April 6, 2024
Clinical and ultrasonographic evaluation of uninjured dominant shoulder in amateur rugby players vs a control group: a pilot studyGiovanni Monteleone, Alfonso Tramontana, Roberto Sorge
Nutrients|October 5, 2019
Impact of Food Additives on Gut HomeostasisFederica Laudisi, Carmine Stolfi, Giovanni Monteleone
Journal of Crohn'S & Colitis|December 22, 2010
Th17 immune response in IBD: A new pathogenic mechanismFlavio Caprioli, Francesco Pallone, Giovanni Monteleone
Pageof 39